In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MedCenterDirect.com

This article was originally published in The Gray Sheet

Executive Summary

E-health procurement portal announces a $12 mil. round of venture financing from New Enterprise Associates. The company is looking to deploy its e-commerce platform to more than 2,000 health care facilities by year-end through exclusive contracts with providers HealthSouth and the National Association of Community Health Centers. The company registered for a $131 mil. initial public offering on March 21 (1"The Gray Sheet" April 17, p. 12)

You may also be interested in...



Medcenterdirect.com E-Commerce B2B Pilot At NACHC Begins April 14

A pilot program which commenced April 14 at seven National Association of Community Health Centers (NACHC) member locations across the U.S. will evaluate medcenterdirect.com's online business-to-business e-commerce marketplace for the purchase and sale of medical and non-medical products, supplies and equipment used by alternate site, hospital and other healthcare providers.

US FDA Expects Joint AdComm Briefing Document, Oncology Chief Says

The combined format is the new default for briefing advisory committee members, US FDA Oncology Center of Excellence Director Pazdur declared.

Parallel Scientific Advice: Is The EMA User Fee Impacting Interest?

EMA charges participants to receive scientific advice through the fledgling program, unlike the US FDA, which may not fit the budgets of some complex generic sponsors. At the same time, sponsors also may simply not be aware the program exists yet.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013696

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel